Related Experiment Video

Updated: Aug 28, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

513

Emerging Therapeutic Strategies of Different Immunotherapy Approaches Combined with PD-1/PD-L1 Blockade in Cervical

Yanjun Ge1, Yuchen Zhang1, Kong-Nan Zhao2,3

  • 1Department of Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.

Drug Design, Development and Therapy
|September 16, 2022
PubMed

Insights

Combining PD-1/PD-L1 inhibitors with other immunotherapies offers a promising strategy to improve treatment outcomes for cervical cancer patients, addressing limitations of current therapies.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • Therapeutic options for advanced and recurrent cervical cancer are limited.
  • Immunotherapy shows promise but has slow investigation and application in cervical cancer.
  • Pembrolizumab (anti-PD-1 mAb) has a low response rate despite FDA approval.

Purpose of the Study:

  • To review anti-PD-1/PD-L1-based immunotherapy in cervical cancer treatment.
  • To summarize combination strategies of PD-1/PD-L1 blockade with other immunotherapies.
  • To discuss enhanced therapeutic benefits of these combined therapies.

Main Methods:

  • Review of current literature on PD-1/PD-L1 inhibitors in cervical cancer.
  • Analysis of emerging immune checkpoints (CTLA-4, TIGIT, LAG-3, TIM-3, A2AR).
  • Synthesis of experimental evidence for combined immunotherapy strategies.

Main Results:

  • Combination strategies involving PD-1/PD-L1 inhibitors and other immunotherapies can enhance antitumor efficacy.
  • Novel immune checkpoints offer new targets for combination therapies.
  • Experimental data supports increased therapeutic benefit from combined approaches.

Conclusions:

  • Combined immunotherapies targeting PD-1/PD-L1 blockade alongside other immune checkpoints represent a significant advancement for cervical cancer treatment.
  • These strategies hold potential to overcome limitations of single-agent immunotherapies and improve patient response rates.
  • Further research and clinical trials are warranted to optimize these combination therapies for cervical cancer.
Keywords:
PD-1/PD-L1cervical cancerclinical practicecombinatorial strategyimmunotherapymechanism

More Related Videos

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.3K
Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

5.8K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
643
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
493
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K